Innate lymphoid cells, which curiously behave like T cells even though they don’t recognize specific antigens, show promise as a potential cancer therapeutic. In the years that followed, other groups ...

Background:Respiratory viruses, including influenza viruses, respiratory syncytial virus (RSV), coronaviruses, and other emerging zoonotic pathogens, remain ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

SARS-CoV-2 has an enzyme that can counteract a cell's innate defense mechanism against viruses, explaining why it is more infectious than the previous SARS and MERS-causing viruses. The discovery may ...

A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and ...

The nanoparticle vaccine allowed the mice’s immune system to produce T cells, white blood cells crucial for fighting ...

A nanoparticle vaccine has shown great promise in preventing three types of cancer in mice, as well as stopping tumors from ...

Seven UCSF investigators are receiving the prestigious award for their research from the National Institutes of Health.

Cancer immunotherapies, including cancer vaccines, harness and amplify the immune system’s natural ability to detect and attack cancer cells. In this illustration, immune T cells (pink) attach to a ...

Researchers have developed a nanoparticle vaccine that prevented melanoma, pancreatic and triple-negative breast cancer in ...